AR081399A1 - Proceso para preparar un compuesto de pirimidinona, compuestos intermediarios en dicho proceso y procesos para repararlos. - Google Patents
Proceso para preparar un compuesto de pirimidinona, compuestos intermediarios en dicho proceso y procesos para repararlos.Info
- Publication number
- AR081399A1 AR081399A1 ARP110101679A AR081399A1 AR 081399 A1 AR081399 A1 AR 081399A1 AR P110101679 A ARP110101679 A AR P110101679A AR 081399 A1 AR081399 A1 AR 081399A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- alkyl
- treating
- heating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Proceso para preparar un compuesto de pirimidinona de formula (1) en la que Ra y Rb junto con los átomos de carbono del anillo de pirimidina a los que están unidos forman un anillo de ciclopentilo; R1 es fenilo, sin sustituir o sustituido con 1 a 3 grupos fluor; R2 es alquilo C1-3 sustituido con NR5R6; o R2 es Het-alquilo C0-2 en el que Het es un anillo heterocíclico de 5 a 7 miembros que contiene N y en el que N puede estar sustituido con alquilo C1-6; R3 es fenilo; R4 es fenilo sin sustituir o sustituido con alquilo C1-6 o de mono a perfluoroalquilo C1-4; y R5 y R6, que pueden ser iguales o diferentes, son alquilo C1-6; dicho proceso comprende realizar una o más de las siguientes etapas de reaccion: (a) tratar un 2- oxociclopentanocarboxilato de alquilo C1-4 con una sal de metal alcalino de glicina para formar un compuesto de formula (A); (b) ciclar un compuesto de dicha formula (A) para formar el ácido hexahidro-1H-ciclopenta[d]pirimidin-1-il)acético de formula (B) por tratamiento de un compuesto de dicha formula (A) con: (i) una sal tiocianato y a) un haloalquilsilano y una fuente de protones, con calentamiento, o b) un ácido anhidro, con calentamiento; o (ii) isotiocianato de trimetilsililo, con calentamiento; (c) formar un ácido tio-4-oxo-4,5,6,7-tetrahidro-1H-ciclopenta[d]pirimidin-1-il)acético de formula (C) en la que n es de 0 a 3, por tratamiento de un compuesto de dicha formula (B) con un reactivo de tio-alquilacion que es un derivado de bencilo de formula (D) en la que n es de 0 a 3 y X es un grupo saliente, en presencia de una base de metal alcalino y/o un carbonato de metal alcalino; (d) tratar un aldehído de formula (E) con una amina, un catalizador de metales pesados e hidrogeno para formar una amina secundaria de formula (F); y (e) formar un compuesto de formula (1) por tratamiento de un compuesto de dicha formula (C) con carbonildiimidazol y la amina secundaria de formula (F) y calentar la mezcla. Compuestos intermediarios en dicho proceso y procesos para prepararlos. Los compuestos de formula (1) son utiles para tratar enfermedades cardiovasculares e inflamatorias tales como aterosclerosis.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34522410P | 2010-05-17 | 2010-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR081399A1 true AR081399A1 (es) | 2012-08-29 |
Family
ID=44992024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101679 AR081399A1 (es) | 2010-05-17 | 2011-05-16 | Proceso para preparar un compuesto de pirimidinona, compuestos intermediarios en dicho proceso y procesos para repararlos. |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9447052B2 (es) |
| EP (1) | EP2571857B1 (es) |
| JP (1) | JP6027529B2 (es) |
| KR (1) | KR20130089157A (es) |
| CN (2) | CN105837520A (es) |
| AR (1) | AR081399A1 (es) |
| AU (1) | AU2011256270B2 (es) |
| BR (1) | BR112012030532A2 (es) |
| CA (1) | CA2799520C (es) |
| CL (1) | CL2012003206A1 (es) |
| CO (1) | CO6630197A2 (es) |
| CR (1) | CR20120630A (es) |
| DO (1) | DOP2012000289A (es) |
| EA (1) | EA026569B1 (es) |
| IL (1) | IL223068A0 (es) |
| MA (1) | MA34301B1 (es) |
| MX (1) | MX2012013387A (es) |
| NZ (1) | NZ603672A (es) |
| PE (1) | PE20130318A1 (es) |
| SG (1) | SG185559A1 (es) |
| TW (1) | TW201209043A (es) |
| UY (1) | UY33388A (es) |
| WO (1) | WO2011146494A1 (es) |
| ZA (1) | ZA201208631B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201209043A (en) * | 2010-05-17 | 2012-03-01 | Glaxo Group Ltd | Novel processes |
| WO2015087239A1 (en) | 2013-12-11 | 2015-06-18 | Ranbaxy Laboratories Limited | Processes for the preparation of darapladib and its intermediates |
| WO2015092687A2 (en) | 2013-12-17 | 2015-06-25 | Ranbaxy Laboratories Limited | Process for the purification of darapladib |
| WO2019063634A1 (en) | 2017-09-26 | 2019-04-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | DARAPLADIB RADIOMARQUÉ, ITS ANALOGUES AND THEIR USE AS IMAGING COMPOUNDS |
| US10866963B2 (en) * | 2017-12-28 | 2020-12-15 | Dropbox, Inc. | File system authentication |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1143516B (de) * | 1961-04-27 | 1963-02-14 | Bayer Ag | Verfahren zur Herstellung von Peptiden |
| US4277465A (en) | 1978-08-26 | 1981-07-07 | Kyoto Yakuhin Kogyo Kabushiki Kaisha | Adjuvant for promoting absorption of therapeutically active substances through the digestive tract |
| US4235776A (en) * | 1979-03-15 | 1980-11-25 | Eli Lilly And Company | Tetrahydro-2H-benzo[c]pyrroles |
| DE2941597A1 (de) * | 1979-10-13 | 1981-04-23 | Basf Ag, 6700 Ludwigshafen | Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
| US4619941A (en) * | 1984-11-19 | 1986-10-28 | American Cyanamid Company | N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents |
| ES2203988T3 (es) * | 1997-11-06 | 2004-04-16 | Smithkline Beecham Plc | Compuestos de pirimidinona y composiciones farmaceuticas que los contienen. |
| US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| AU1520300A (en) | 1998-11-05 | 2000-05-29 | Biocryst Pharmaceuticals, Inc. | New cyclopentane and cyclopentene compounds and use for detecting influenza virus |
| TR200103216T2 (tr) * | 1999-05-01 | 2002-04-22 | Smithkline Beecham P.L.C. | Pirimidinon bileşimleri |
| AU2001235466B2 (en) * | 2000-02-16 | 2004-04-22 | Glaxo Group Limited | Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors |
| GB0119795D0 (en) | 2001-08-14 | 2001-10-03 | Smithkline Beecham Plc | Novel process |
| TW201209043A (en) * | 2010-05-17 | 2012-03-01 | Glaxo Group Ltd | Novel processes |
-
2011
- 2011-05-16 TW TW100117029A patent/TW201209043A/zh unknown
- 2011-05-16 UY UY33388A patent/UY33388A/es not_active Application Discontinuation
- 2011-05-16 AR ARP110101679 patent/AR081399A1/es unknown
- 2011-05-17 BR BR112012030532A patent/BR112012030532A2/pt not_active IP Right Cessation
- 2011-05-17 NZ NZ60367211A patent/NZ603672A/en not_active IP Right Cessation
- 2011-05-17 PE PE2012002160A patent/PE20130318A1/es not_active Application Discontinuation
- 2011-05-17 CA CA2799520A patent/CA2799520C/en not_active Expired - Fee Related
- 2011-05-17 MA MA35441A patent/MA34301B1/fr unknown
- 2011-05-17 EA EA201291235A patent/EA026569B1/ru not_active IP Right Cessation
- 2011-05-17 SG SG2012083648A patent/SG185559A1/en unknown
- 2011-05-17 JP JP2013511295A patent/JP6027529B2/ja not_active Expired - Fee Related
- 2011-05-17 WO PCT/US2011/036821 patent/WO2011146494A1/en active Application Filing
- 2011-05-17 AU AU2011256270A patent/AU2011256270B2/en not_active Ceased
- 2011-05-17 US US13/698,102 patent/US9447052B2/en not_active Expired - Fee Related
- 2011-05-17 CN CN201610182606.0A patent/CN105837520A/zh active Pending
- 2011-05-17 CN CN201180035126.7A patent/CN103003249B/zh not_active Expired - Fee Related
- 2011-05-17 MX MX2012013387A patent/MX2012013387A/es unknown
- 2011-05-17 EP EP11784095.9A patent/EP2571857B1/en active Active
- 2011-05-17 KR KR20127032795A patent/KR20130089157A/ko active IP Right Grant
-
2012
- 2012-11-15 IL IL223068A patent/IL223068A0/en unknown
- 2012-11-15 DO DO2012000289A patent/DOP2012000289A/es unknown
- 2012-11-16 CL CL2012003206A patent/CL2012003206A1/es unknown
- 2012-11-16 ZA ZA2012/08631A patent/ZA201208631B/en unknown
- 2012-11-16 CO CO12208170A patent/CO6630197A2/es unknown
- 2012-12-12 CR CR20120630A patent/CR20120630A/es unknown
-
2016
- 2016-08-12 US US15/235,468 patent/US9725420B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR081399A1 (es) | Proceso para preparar un compuesto de pirimidinona, compuestos intermediarios en dicho proceso y procesos para repararlos. | |
| AR061924A1 (es) | Proceso para elaborar 2- amino -5 - halobenzamidas 3- sustituidas | |
| PE20171102A1 (es) | Procesos para preparar inhibidores de jak y compuestos intermediarios relacionados | |
| AR049374A1 (es) | Sintesis de compuestos de ester y acido borico | |
| PE20230156A1 (es) | Sal de acido clorhidrico de (r)-4-(3-((s)-1-(4-amino-3-metil-1h pirazolo[3,4-d]pirimidin-1-il)etil)-5-cloro-2-etoxi-6-fluorofenil)pirrolidin-2-ona | |
| EA201391522A1 (ru) | Способ получения соединений для применения в качестве ингибиторов sglt2 | |
| AR083213A1 (es) | Proceso de preparacion de derivados pirimidinicos, compuestos intermediarios y proceso para prepararlos | |
| IN2014MN02496A (es) | ||
| MX2014006992A (es) | Disales de acido malonico y metodo para preparar dihaluros de malonilo. | |
| PE20121438A1 (es) | Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a | |
| CY1119452T1 (el) | Μια μεθοδος παρασκευης 2-αιθοξυ-1-(2'-((υδροξυamino) ιμινομεθυλο) διφαινυλ-4-υλο) μεθυλο)-1η- βενζο (d) ιμιδαζολο-7-καρβοξυλικο οξυ και τους εστερες αυτου | |
| BR112018011518A2 (pt) | método de produção de derivado de amida aromática | |
| CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
| MX2010001229A (es) | Procedimiento para la resolucion de zopiclona y compuestos intermedios. | |
| EA201490998A1 (ru) | Способ получения сложных эфиров (5-фтор-2-метил-3-хинолин-2-илметил-индол-1-ил)-уксусной кислоты | |
| Nakata et al. | (R)-(+)-N-Methylbenzoguanidine ((R)-NMBG) catalyzed kinetic resolution of racemic secondary benzylic alcohols with free carboxylic acids by asymmetric esterification | |
| AR051936A1 (es) | Proceso para la preparacion de pirazoles | |
| MX354498B (es) | Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida. | |
| JP2013530948A5 (es) | ||
| EA201990236A1 (ru) | Новые способы получения стимуляторов растворимой гуанилатциклазы | |
| AR077332A1 (es) | Procesos para la alquilacion de pirazoles | |
| PE20070114A1 (es) | Inhibidor de tubulina y proceso para su preparacion | |
| CN101456825B (zh) | 一种丙烯腈衍生物的制备方法 | |
| NZ711329A (en) | A process for preparation of (2s, 5r)- sulfuric acid mono-{ [(4-aminopiperidin-4-yl) carbonyl]-7-oxo-1,6-diaza-bicyclo[3.2.1]-oct-6-yl} ester | |
| RU2013126415A (ru) | ПРОИЗВОДНЫЕ ПИРАЗИНО[2,3-d]ИЗОКСАЗОЛА |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |